Revelation of subclinical left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus using 2016 ASE/ EACVI guidelines.
2016 ASE/EACVI guidelines
Diabetic cardiomyopathy
Diastology
Left ventricular diastolic dysfunction
Tissue Doppler imaging
Journal
Caspian journal of internal medicine
ISSN: 2008-6164
Titre abrégé: Caspian J Intern Med
Pays: Iran
ID NLM: 101523876
Informations de publication
Date de publication:
2021
2021
Historique:
received:
22
05
2020
revised:
26
12
2020
accepted:
28
12
2020
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
ppublish
Résumé
Few studies have used the 2016 American Society of Echocardiography/ European Association of Cardiovascular Imaging (ASE/EACVI) guidelines to detect left ventricular diastolic dysfunction (LVDD) among asymptomatic normotensive type 2 diabetes mellitus (T2DM) patients. 200 asymptomatic non-hypertensive diabetic cases and 281 controls matched for age and body mass index without evidence of arrhythmias, valvular, myocardial, pericardial or coronary artery disease underwent diastology assessment using 2 dimensional and M-mode echocardiography along with tissue Doppler imaging. The presence of LVDD was seen to be significantly higher among the members of the diabetic group compared to the controls (35 vs. 14; P=0.001). The diabetics with LVDD had a longer duration of diabetes {8.04±7.75 vs. 5.27±5.49 years; P=0.04}, along with higher glycated hemoglobin (HbA1c) {8.40±1.38 vs. 7.80±1.60% ; P=0.05}, fasting blood glucose (FBS) {211.35±78.15 vs. 187.89±107.90 mg/dL; P=0.009, 2 hour post prandial blood glucose} (PPBS) {237.89±107.9 vs. 211.35±78.15 mg/dL; P=0.04}, serum triglyceride (TG) {246.91±171.82 vs. 163.44±99.37 mg/dL; P=0.008} yet had lower serum very low density lipoprotein levels (VLDL) {19.74±15.01 vs. 27.61±17.89 mg/dL; P=0.01}. This is one of the few studies so far to have demonstrated a higher occurrence of LVDD specifically among asymptomatic normotensive T2DM patients using the 2016 ASE/EACVI guidelines.
Sections du résumé
BACKGROUND
BACKGROUND
Few studies have used the 2016 American Society of Echocardiography/ European Association of Cardiovascular Imaging (ASE/EACVI) guidelines to detect left ventricular diastolic dysfunction (LVDD) among asymptomatic normotensive type 2 diabetes mellitus (T2DM) patients.
METHODS
METHODS
200 asymptomatic non-hypertensive diabetic cases and 281 controls matched for age and body mass index without evidence of arrhythmias, valvular, myocardial, pericardial or coronary artery disease underwent diastology assessment using 2 dimensional and M-mode echocardiography along with tissue Doppler imaging.
RESULTS
RESULTS
The presence of LVDD was seen to be significantly higher among the members of the diabetic group compared to the controls (35 vs. 14; P=0.001). The diabetics with LVDD had a longer duration of diabetes {8.04±7.75 vs. 5.27±5.49 years; P=0.04}, along with higher glycated hemoglobin (HbA1c) {8.40±1.38 vs. 7.80±1.60% ; P=0.05}, fasting blood glucose (FBS) {211.35±78.15 vs. 187.89±107.90 mg/dL; P=0.009, 2 hour post prandial blood glucose} (PPBS) {237.89±107.9 vs. 211.35±78.15 mg/dL; P=0.04}, serum triglyceride (TG) {246.91±171.82 vs. 163.44±99.37 mg/dL; P=0.008} yet had lower serum very low density lipoprotein levels (VLDL) {19.74±15.01 vs. 27.61±17.89 mg/dL; P=0.01}.
CONCLUSION
CONCLUSIONS
This is one of the few studies so far to have demonstrated a higher occurrence of LVDD specifically among asymptomatic normotensive T2DM patients using the 2016 ASE/EACVI guidelines.
Identifiants
pubmed: 34820067
doi: 10.22088/cjim.12.4.586
pmc: PMC8590406
doi:
Types de publication
Journal Article
Langues
eng
Pagination
586-592Déclaration de conflit d'intérêts
None declared
Références
J Am Coll Cardiol. 2017 Oct 3;70(14):1717-1719
pubmed: 28958327
Arch Cardiovasc Dis. 2012 Apr;105(4):218-25
pubmed: 22633296
Diab Vasc Dis Res. 2018 Nov;15(6):477-493
pubmed: 30037278
Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):380-386
pubmed: 29236978
J Cardiovasc Dis Res. 2011 Oct;2(4):213-22
pubmed: 22135479
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Am J Cardiol. 1988 May 1;61(13):1140-3
pubmed: 3364373
Acta Diabetol. 2014 Dec;51(6):999-1005
pubmed: 25274395
Circ Res. 2018 Feb 16;122(4):624-638
pubmed: 29449364
J Am Coll Cardiol. 2019 Feb 12;73(5):602-611
pubmed: 30732715
Heart. 2018 Mar;104(5):377-384
pubmed: 29305560
Am J Cardiol. 2009 May 15;103(10):1463-6
pubmed: 19427447
Diabetes Care. 2014 Nov;37(11):3092-7
pubmed: 25193530
J Am Soc Echocardiogr. 2018 Jan;31(1):79-88
pubmed: 29111121
Eur J Clin Invest. 2016 Nov;46(11):947-953
pubmed: 27600276
Diabetes Metab. 2007 Feb;33(1):61-7
pubmed: 17258922
Annu Rev Med. 2018 Jan 29;69:65-79
pubmed: 29414252
N Engl J Med. 2016 Nov 10;375(19):1868-1877
pubmed: 27959663
Am J Cardiol. 2004 Apr 1;93(7):870-5
pubmed: 15050491